Aquestive Current Ratio from 2010 to 2024

AQST Stock  USD 3.52  0.07  1.95%   
Aquestive Therapeutics Current Ratio yearly trend continues to be comparatively stable with very little volatility. Current Ratio is likely to outpace its year average in 2024. Current Ratio is a liquidity ratio that measures a company's ability to pay short-term obligations or those due within one year. It compares a firm's current assets to its current liabilities. View All Fundamentals
 
Current Ratio  
First Reported
2010-12-31
Previous Quarter
2.23760105
Current Value
2.4
Quarterly Volatility
0.52227292
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Aquestive Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Aquestive Therapeutics' main balance sheet or income statement drivers, such as Interest Expense of 9.5 M, Selling General Administrative of 43.5 M or Total Revenue of 48.2 M, as well as many indicators such as Price To Sales Ratio of 3.76, Dividend Yield of 0.0 or Days Sales Outstanding of 47.57. Aquestive financial statements analysis is a perfect complement when working with Aquestive Therapeutics Valuation or Volatility modules.
  
Check out the analysis of Aquestive Therapeutics Correlation against competitors.
For more information on how to buy Aquestive Stock please use our How to Invest in Aquestive Therapeutics guide.

Latest Aquestive Therapeutics' Current Ratio Growth Pattern

Below is the plot of the Current Ratio of Aquestive Therapeutics over the last few years. It is a liquidity ratio that measures a company's ability to pay short-term obligations or those due within one year. It compares a firm's current assets to its current liabilities. Aquestive Therapeutics' Current Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Aquestive Therapeutics' overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 1.47 X10 Years Trend
Very volatile
   Current Ratio   
       Timeline  

Aquestive Current Ratio Regression Statistics

Arithmetic Mean2.19
Geometric Mean2.13
Coefficient Of Variation23.89
Mean Deviation0.24
Median2.16
Standard Deviation0.52
Sample Variance0.27
Range2.6764
R-Value(0.02)
Mean Square Error0.29
R-Squared0.0004
Significance0.94
Slope(0)
Total Sum of Squares3.82

Aquestive Current Ratio History

2024 2.4
2023 2.24
2022 1.01
2021 2.15
2020 2.11
2019 3.68
2018 2.25

About Aquestive Therapeutics Financial Statements

Aquestive Therapeutics shareholders use historical fundamental indicators, such as Current Ratio, to determine how well the company is positioned to perform in the future. Although Aquestive Therapeutics investors may analyze each financial statement separately, they are all interrelated. The changes in Aquestive Therapeutics' assets and liabilities, for example, are also reflected in the revenues and expenses on on Aquestive Therapeutics' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Current Ratio 2.24  2.40 

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Aquestive Stock Analysis

When running Aquestive Therapeutics' price analysis, check to measure Aquestive Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aquestive Therapeutics is operating at the current time. Most of Aquestive Therapeutics' value examination focuses on studying past and present price action to predict the probability of Aquestive Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aquestive Therapeutics' price. Additionally, you may evaluate how the addition of Aquestive Therapeutics to your portfolios can decrease your overall portfolio volatility.